Answers are grounded in this paper and cite their sources.
This archive contains the complete computational record of a multi-target virtual screen of AfroDb, a library of natural products from African medicinal plants, against four mechanistically distinct Staphylococcus aureus drug targets: penicillin-binding protein 2a (PDB 1MWU), dihydrofolate reductase (2W9H), enoyl-ACP reductase FabI (3GR6) and the ATPase domain of DNA gyrase subunit B (3TTZ). The pipeline ran in four stages deduplication and Lipinski plus lead-likeness filtering of 903 unique structures down to 155 lead-like candidates; AutoDock Vina docking of those candidates alongside one clinically used reference inhibitor per target (156 ligands per target); ADMET prediction with ADMET-AI; and flow-limited physiologically based pharmacokinetic simulation of tissue exposure for the resulting shortlist. The archive provides the input library and prepared receptor files, a single machine-readable parameters.json recording every threshold and docking box, the analysis scripts, the raw docking-engine output for every run, the ADMET and PBPK result tables, the publication figures, a pinned software environment and an md5 file manifest. Reference inhibitors were embedded in each ranking as an explicit calibration benchmark: calibration succeeded for FabI (triclosan, rank 2 of 156) and failed for DHFR (trimethoprim, rank 141 of 156), so the four target columns in this dataset do not carry equal evidential weight and should not be averaged
No takes yet. Share an insight, caveat, or question.
Kapisha et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: